Biorestorative Therapies Inc (BRTX) Stock Price, Quote & News

Company Profile

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral di...

Industry: Biotechnology

Sector: Healthcare

Phone: 631 760 8100

Website: www.biorestorative.com

Address:

40 Marcus Drive, Suite 1, Melville, United States

Amiabull Feb. 23 at 12:54 PM

$BRTX Gapping up! - should be a fun day! 😜

0 · Reply

Kesiya Feb. 23 at 3:12 AM

🎯💎TOP 4 Stocks with High Potential for Upward Movement During/Overnight -Premarket🚀⚡📊 1.$BRTX 2.$SGN 3.$TIRX 4.$KXIN

1 · Reply

taneraydar Feb. 23 at 2:52 AM

$BRTX this week filling the gap @.40

0 · Reply

GuruChartist Feb. 22 at 8:40 PM

$PFSA $BRTX $GOVX Wonder if these low RSI's will translate into a nice bounce in the near future. https://www.reddit.com/r/pennystocks/comments/1rbwqv2/companies_with_upcoming_corporate_developments/ It is very rare to see a RSI under 15 like BRTX.

0 · Reply

Kesiya Feb. 21 at 12:56 AM

$BRTX Load more+!!

0 · Reply

Ambitionneverdies Feb. 21 at 12:35 AM

$BRTX WTF IS GOING ON IN AF

0 · Reply

4trax Feb. 20 at 9:58 PM

$BRTX look at it,junk

0 · Reply

Peak_Big Feb. 20 at 9:21 PM

$BRTX literal cowshit will be more profitable than investing here.

1 · Reply

Peak_Big Feb. 20 at 9:16 PM

$BRTX will drop to .15 monday, still no true bull to be seen buy whatever you want its worthless 😂😂😂

0 · Reply

Kesiya Feb. 20 at 8:31 PM

$BRTX Thank you for the discount!/My friends and I bought more!

0 · Reply

BioRestorative Announces Closing of $5.0 Million Public Offering

Feb 11, 2026, 10:30 PM EST - 11 days ago

BioRestorative Announces Pricing of $5.0 Million Public Offering

Feb 11, 2026, 7:30 AM EST - 12 days ago

BioRestorative Announces Positive Outcome from Type B Meeting with FDA

Nov 12, 2025, 6:51 PM EST - 3 months ago

BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:30 PM EST - 3 months ago

BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025

Oct 27, 2025, 7:30 AM EDT - 4 months ago

BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market

Oct 22, 2025, 9:35 AM EDT - 4 months ago

BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio

Oct 15, 2025, 9:35 AM EDT - 4 months ago

BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit

Oct 7, 2025, 9:25 AM EDT - 4 months ago

BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show”

Oct 6, 2025, 2:28 PM EDT - 4 months ago

BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market

Aug 12, 2025, 7:53 PM EDT - 6 months ago

BioRestorative Therapies, Inc. (BRTX) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:30 PM EDT - 7 months ago

BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025

Jun 18, 2025, 9:35 AM EDT - 8 months ago

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates

Jun 17, 2025, 9:25 AM EDT - 8 months ago

BioRestorative Announces Share Repurchase Program

Jun 13, 2025, 7:45 AM EDT - 9 months ago

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

Jun 9, 2025, 7:45 AM EDT - 9 months ago

BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025

May 14, 2025, 8:46 PM EDT - 10 months ago

BioRestorative Therapies, Inc. (BRTX) Q1 2025 Earnings Call Transcript

May 13, 2025, 9:15 AM EDT - 10 months ago

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

May 8, 2025, 4:30 PM EDT - 10 months ago

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025

May 7, 2025, 9:15 AM EDT - 10 months ago

BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025

Apr 15, 2025, 8:30 AM EDT - 11 months ago

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities

Apr 10, 2025, 9:15 AM EDT - 11 months ago

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States

Mar 27, 2025, 8:10 PM EDT - 11 months ago

BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 9:45 AM EST - 1 year ago

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain

Feb 26, 2025, 8:15 PM EST - 1 year ago

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update

Feb 20, 2025, 8:30 AM EST - 1 year ago

BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program

Dec 5, 2024, 6:45 AM EST - 1 year ago

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program

Nov 13, 2024, 7:53 PM EST - 1 year ago

BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:10 AM EST - 1 year ago

BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health

Oct 3, 2024, 4:15 PM EDT - 1 year ago

BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Sep 19, 2024, 6:55 AM EDT - 1 year ago

BioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem® Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs

Aug 13, 2024, 11:26 PM EDT - 1 year ago

BioRestorative Therapies, Inc. (BRTX) Q2 2024 Earnings Call Transcript

Jul 23, 2024, 7:10 AM EDT - 1 year ago

BioRestorative Therapies' Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine

Jun 27, 2024, 7:40 AM EDT - 1 year ago

BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program

Jun 17, 2024, 7:05 AM EDT - 1 year ago

BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results

Jun 13, 2024, 7:00 AM EDT - 1 year ago

BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program

Jun 4, 2024, 8:50 AM EDT - 1 year ago

BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference

May 24, 2024, 7:45 PM EDT - 1 year ago

BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice

May 15, 2024, 9:00 AM EDT - 1 year ago

BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market

May 14, 2024, 7:08 PM EDT - 1 year ago

BioRestorative Therapies, Inc. (BRTX) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:10 PM EDT - 1 year ago

BioRestorative Therapies Provides First Quarter 2024 Business Update

May 8, 2024, 7:30 AM EDT - 1 year ago

BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity

Apr 30, 2024, 4:15 PM EDT - 1 year ago

BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Apr 30, 2024, 7:30 AM EDT - 1 year ago

BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology

Apr 16, 2024, 7:45 AM EDT - 2 years ago

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment

Apr 8, 2024, 7:45 AM EDT - 2 years ago

BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease

Apr 3, 2024, 4:38 PM EDT - 2 years ago

BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants

Apr 1, 2024, 7:45 AM EDT - 2 years ago

BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K

Mar 11, 2024, 4:15 PM EDT - 2 years ago

BioRestorative Therapies to Participate in the 36th Annual ROTH Conference

Feb 14, 2024, 9:15 AM EST - 2 years ago

BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting

Amiabull Feb. 23 at 12:54 PM

$BRTX Gapping up! - should be a fun day! 😜

0 · Reply

Kesiya Feb. 23 at 3:12 AM

🎯💎TOP 4 Stocks with High Potential for Upward Movement During/Overnight -Premarket🚀⚡📊 1.$BRTX 2.$SGN 3.$TIRX 4.$KXIN

1 · Reply

taneraydar Feb. 23 at 2:52 AM

$BRTX this week filling the gap @.40

0 · Reply

GuruChartist Feb. 22 at 8:40 PM

0 · Reply

Kesiya Feb. 21 at 12:56 AM

$BRTX Load more+!!

0 · Reply

Ambitionneverdies Feb. 21 at 12:35 AM

$BRTX WTF IS GOING ON IN AF

0 · Reply

4trax Feb. 20 at 9:58 PM

$BRTX look at it,junk

0 · Reply

Peak_Big Feb. 20 at 9:21 PM

$BRTX literal cowshit will be more profitable than investing here.

1 · Reply

Peak_Big Feb. 20 at 9:16 PM

$BRTX will drop to .15 monday, still no true bull to be seen buy whatever you want its worthless 😂😂😂

0 · Reply

Kesiya Feb. 20 at 8:31 PM

$BRTX Thank you for the discount!/My friends and I bought more!

0 · Reply

SirHoppington Feb. 20 at 8:19 PM

$BRTX it’s going to be okay lol. See everybody next week.

0 · Reply

Ambitionneverdies Feb. 20 at 7:40 PM

$BRTX WILL BUY MORE HERE

0 · Reply

tytyada Feb. 20 at 7:34 PM

$BRTX this will move . Only a matter of time

0 · Reply

Rahmmy Feb. 20 at 7:20 PM

$BRTX has anyone ever seen a company in which the CEO has driven the stock price down 99.99999% and he keeps his job, as to the board members? I’ve never seen a legitimate company do that.

0 · Reply

Ambitionneverdies Feb. 20 at 6:54 PM

$BRTX ENOUGH….NOW GO UP CRAZYYYYY

0 · Reply

Peak_Big Feb. 20 at 6:01 PM

$BRTX called it! Broke shareholders dont give a fuck how low it goes theyll buy more!!

1 · Reply

Amiabull Feb. 20 at 5:41 PM

$BRTX on par as planned - watch AH ;)

0 · Reply

Nousernam3 Feb. 20 at 5:19 PM

$BRTX this so finished

0 · Reply

TheSniperGuy Feb. 20 at 5:18 PM

$BRTX Tell us what you own? A stock that did offering at 0.35 while was trading above $1 not being able to even raise the full 10M they need it? Cheap warrants attached to them shares at 0.35 also? 90 days no dilution? Tell us

0 · Reply

1Minute Feb. 20 at 5:05 PM

$BRTX Bidding at .19ish

0 · Reply

gobuckeyes21 Feb. 20 at 4:46 PM

$BRTX called it a year ago almost to the day. Lance will continue to destroy shareholders. I’m guessing another RS and or offering. How low can she go????

0 · Reply

Peak_Big Feb. 20 at 4:24 PM

$BRTX so much fake excitement here. Its only going lower. Noone here wants to buy higher prices so enjoy lower and lower prices!!

1 · Reply

Market Cap	1.98M
Revenue (ttm)	400,000.00
Net Income (ttm)	-8.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,245.00%
Debt to Equity Ratio	0.00

Volume	7,166,600
Avg Vol	1,805,524
Day's Range	N/A - N/A
Shares Out	9.05M
Stochastic %K	1%
Beta	0.39
Analysts	Strong Sell
Price Target	$13.00